NFLX Long 4:1 R:R
NFLX is at support, which has held a few times already.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot.
I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.